Showing results (21-30 of 172) with videos related to
Sort By:
Pageof 18
Blood|October 9, 2004
The pathophysiologic role of VEGF in hematologic malignancies: therapeutic implicationsKlaus Podar, Kenneth C AndersonWiener Medizinische Wochenschrift (1946)|January 24, 2009
[Bisphosphonates and osteonecrosis of the jaw--an increasing challenge in palliative care]Dora Beke, Martin PecherstorferCell Cycle (Georgetown, Tex.)|March 14, 2007
Inhibition of VEGF signaling pathways in multiple myeloma and other malignanciesKlaus Podar, Kenneth C AndersonCancer Treatment and Research|October 4, 2016
Targeting the Bone Marrow MicroenvironmentMichele Moschetta, Yawara Kawano, Klaus PodarJournal for Immunotherapy of Cancer|May 3, 2024
Favorable impact of PD1/PD-L1 antagonists on bone remodeling: an exploratory prospective clinical study and ex vivo validationTamara Gassner, Christina Chittilappilly, Theo Pirich, et al.Treatments in Endocrinology|June 22, 2005
Current management strategies for hypercalcemiaMartin Pecherstorfer, Karin Brenner, Niklas ZojerWiener Medizinische Wochenschrift (1946)|September 19, 2017
Symptomatic treatment of dyspnea in advanced cancer patients : A narrative review of the current literatureMatthäus Strieder, Martin Pecherstorfer, Gudrun KreyeJournal of Oncology|August 31, 2011
Targeting the tumor microenvironment: focus on angiogenesisFengjuan Fan, Alexander Schimming, Dirk Jaeger, et al.Expert Opinion on Emerging Drugs|July 23, 2019
Emerging protein kinase inhibitors for the treatment of multiple myelomaJudith Lind, Felix Czernilofsky, Sonia Vallet, et al.Frontiers in Oncology|January 11, 2020
Is Neuronal Histamine Signaling Involved in Cancer Cachexia? Implications and PerspectivesHannes Zwickl, Elisabeth Zwickl-Traxler, Martin PecherstorferPageof 18